Inflammatory markers in clinical practice

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 2 II, 2000, Pages

  Wilson, N ^a   Pedersen, S ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN; NITRIC OXIDE;

ASTHMA; BLOOD LEVEL; BREATH ANALYSIS; CHRONIC LUNG DISEASE; CLINICAL FEATURE; CLINICAL PRACTICE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; EOSINOPHILIA; HUMAN; PATIENT COMPLIANCE; PREDICTION; PREMATURITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; URINE LEVEL;

EID: 0033897284     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.supplement_1.maic-13     Document Type: Review

References (43)

1. Detection of nonvolatile macromolecules in breath: A possible diagnostic tool?
2. Can eosinophil-derived proteins be used to diagnose or to monitor childhood asthma?
3. Serum eosinophil cationic protein in the evaluation of asthma severity in children
4. Asthma in children less than 5 years of age: Eosinophils and serum levels of the eosinophil proteins ECP and EPX in relation to atopy and symptoms
5. Serum eosinophil cationic protein (ECP) and eosinophil protein X (EPX) in childhood asthma: The influence of atopy
6. Inflammation markers and symptom activity in children with bronchial asthma: Influence of atopy and eczema
7. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma
8. Epidemiological association of airway inflammation with asthma symptoms and airway hyperresponsiveness in childhood
9. Asthma - Time for a change of name?
10. Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: Results of a factor analysis
11. Nasal and lower airway level of nitric oxide in children with primary ciliary dyskinesia
12. Elevated levels of exhaled nitric oxide in bronchiectasis
13. Markers of allergy and inflammation
14. Sensitization to inhalant allergens in wheezing infants is predictive of the development of infantile asthma
15. Prospective study of risk factors for early and persistent wheezing in childhood
16. High levels of eosinophil cationic protein in wheezing infants predict the development of asthma
17. Nasopharyngeal eosinophil cationic protein in bronchiolitis: Relation to viral findings and subsequent wheezing
18. Is serum eosinophil cationic protein in bronchiolitis a predictor of asthma?
19. Eosinophil cationic protein in nasal secretion and in serum and myeloperoxidase in serum in respiratory syncytial virus bronchiolitis: Relation to asthma and atopy
20. Markers of pulmonary inflammation in tracheobronchial fluid of premature infants with respiratory distress syndrome
21. Eosinophilia in premature infants: Correlation with chronic lung disease
22. Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity
23. Clinical utility of serum levels of eosinophil cationic protein (ECP) for monitoring and predicting clinical course in childhood asthma
24. The relationship of serum-eosinophil cationic protein and eosinophil count to disease activity in children with bronchial asthma
25. Eosinophils and eosinophil-derived proteins in children with moderate asthma
26. Orally exhaled nitric oxide levels are related to the degree of blood eosinophilia in atopic children with mild-intermittent asthma
27. Total blood eosinophils, serum eoslnophil cationic protein and eosinophil protein X in childhood asthma: Relation to disease status and therapy
28. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD
29. Urinary eosinophil protein X in children with atopic asthma: A useful marker of antiinflammatory treatment
30. Lack of relationship between eosinophil cationic protein and eosinophil protein X in nasal lavage and urine and the severity of childhood asthma in a six month follow-up study
31. Eosinophilic activation in cystic fibrosis
32. Serum level of eosinophil cationic protein in patients with chronic cough: Relationship to blood eosinophils and airway hyperresponsiveness
33. Eosinophil cationic protein in nasopharyngeal secretions and serum of infants infected with respiratory syncytial virus
34. Eosinophil cationic protein in the sera of patients with Mycoplasma pneumonia
35. Serum eosinophil cationic protein, eosinophil protein X and eosinophil peroxidase in relation to pulmonary function in cystic fibrosis
36. Exhaled nitric oxide and sputum eosinophil markers of inflammation in asthmatic children
37. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma
38. What are the goals of treating pediatric asthma?
39. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen and Hanburys Limited UK Study Group
40. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids
41. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment: The AMPUL Study Group
42. Persistence of sputum eosinophilia in children with controlled asthma when compared with healthy children
43. Incidence and prognosis of asthma and wheezing illness from early childhood to age 33 in a national British cohort